Healthequity SCR

Healthequity SCR is a venture capital firm specializing in early-stage projects within the healthcare sector, focusing on medical devices, biotechnology, and healthcare services. The firm is promoted by Col·legi de Metges de Barcelona and Grupo Financiero Riva y García, with initial capital of approximately €7 million, extendable up to €15 million. Healthequity SCR is backed by pharmaceutical companies and institutional investors, aiming to invest between €1 million and €3 million in innovative companies with sustainable business models.

The firm's investment strategy targets innovative companies in potential markets where significant improvements can be achieved, led by qualified teams. Healthequity SCR seeks to invest in companies at the preclinical stage and also participates in Series A investments for companies approximately 1-2 years away from First-in-Human trials. The firm primarily focuses on European-based opportunities, with a special emphasis on Spanish biotechnology companies developing innovative drugs, particularly in Advanced Therapies and Synthetic Biology.

Healthequity SCR has a qualified professional team with scientific-technical and financial expertise to analyze and close investments, bringing value to the portfolio company. Additionally, the firm has an extensive network and strategic alliances within the healthcare ecosystem, enabling it to support the growth and development of its portfolio companies effectively.